Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Advances in High-Content Imaging and Informatics: A Joint Special Collection with Society for Biomolecular Imaging and Informatics and SLAS.

SLAS discovery : advancing life sciences R & D·2021

Same author

Inhibition of IRF5 cellular activity with cell-penetrating peptides that target homodimerization.

Science advances·2020

Same author

Society of Biomolecular Imaging and Informatics High-Content Screening/High-Content Analysis Preclinical Translational Imaging Colloquium: How Emerging Technologies in Disease Models, High-Content Imaging, and Data Analytics Are Changing Our Approach to Drug Discovery.

Assay and drug development technologies·2019

Same author

Society of Biomolecular Imaging and Informatics High-Content Screening/High-Content Analysis Emerging Technologies in Biological Models, When and Why?

Assay and drug development technologies·2018

Same author

SBI<sup>2</sup> HCS/HCA 3D Imaging: Best Practices and Unmet Needs Colloquium.

Assay and drug development technologies·2017

Same author

BET bromodomain proteins mediate downstream signaling events following growth factor stimulation in human lung fibroblasts and are involved in bleomycin-induced pulmonary fibrosis.

Molecular pharmacology·2012

Search research articles

Related Experiment Video

Updated: Jun 22, 2026

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents (HPHC)

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents (HPHC)

Published on: May 10, 2016

Instrumental considerations in high content screening.

Chris Shumate¹, Ann F Hoffman

¹V.P. Business Development, Blueshift Biotechnologies, Inc., 245 Santa Ana Court, Sunnyvale, CA 94085, USA.

Combinatorial Chemistry & High Throughput Screening

|June 18, 2009

Summary

This summary is machine-generated.

This study reviews optical imaging platforms, including laser line scanners, nonconfocal, and confocal imagers, for biological analysis. It guides matching biological assays with hardware for efficient drug discovery screening.

More Related Videos

High Content Screening in Neurodegenerative Diseases

High Content Screening in Neurodegenerative Diseases

Published on: January 6, 2012

A Fluorescence-based Lymphocyte Assay Suitable for High-throughput Screening of Small Molecules

A Fluorescence-based Lymphocyte Assay Suitable for High-throughput Screening of Small Molecules

Published on: March 10, 2017

Related Experiment Videos

Last Updated: Jun 22, 2026

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents (HPHC)

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents (HPHC)

Published on: May 10, 2016

High Content Screening in Neurodegenerative Diseases

High Content Screening in Neurodegenerative Diseases

Published on: January 6, 2012

A Fluorescence-based Lymphocyte Assay Suitable for High-throughput Screening of Small Molecules

A Fluorescence-based Lymphocyte Assay Suitable for High-throughput Screening of Small Molecules

Published on: March 10, 2017

Area of Science:

Life Sciences
Biotechnology
Optical Imaging

Background:

Diverse biological queries are analyzed using automated optical imaging platforms.
These platforms range from analyzing limited samples to millions, crucial for pharmaceutical drug discovery.
Key platforms include laser line scanners, nonconfocal imagers, and confocal imagers.

Purpose of the Study:

To review distinguishing optical pathway and hardware features of automated imaging platforms.
To guide the selection of appropriate imaging hardware for biological assays.
To consider factors like resolution, throughput, biology, cell types, and screening goals.

Main Methods:

Review of optical pathway and hardware features across laser line scanners, nonconfocal, and confocal imagers.
Discussion of factors influencing the matching of biological assays to imaging platforms.
Consideration of biological context, cell types, and screening objectives.

Main Results:

Identified key distinctions in optical pathways and hardware among automated imaging platforms.
Highlighted the trade-offs between resolution and throughput in imaging system selection.
Provided considerations for aligning biological assay requirements with imaging hardware capabilities.

Conclusions:

Matching biological assays to specific imaging platforms requires careful consideration of hardware features and biological context.
Optimizing the use of optics is essential for maximizing both resolution and throughput.
Informed hardware selection is critical for efficient and effective biological screening in drug discovery.